🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Walgreens flooded Florida with addictive opioids, lawyer tells jury

Published 04/11/2022, 06:08 AM
Updated 04/11/2022, 06:31 PM
© Reuters. FILE PHOTO: A Walgreens store is seen in Chicago, Illinois, U.S. February 11, 2021.  REUTERS/Eileen T. Meslar
TEVA
-
AGN
-
CVS
-
WBA
-
ENDPQ
-

By Dietrich Knauth

(Reuters) -Walgreens Boots Alliance Inc supplied billions of opioid pills to drug addicts and criminals, contributing to an addiction epidemic in Florida, a lawyer for the state said on Monday in a civil trial against the pharmacy chain.

Walgreens filled one in four opioid prescriptions in Florida between 1999 and 2020, and failed to investigate red flags that could have prevented drugs from being diverted for illegal use, the state's lawyer Jim Webster said as jurors heard opening statements in the trial held in New Port Richey.

"Walgreens was the last line of defense in preventing improper distribution of opioids," Webster said. "It was the entity that actually put the opioids in the hands of people addicted to opioids and the hands of criminals."

Walgreens, which has denied the allegations, is the final remaining defendant in the trial taking place before Judge Kimberly Sharpe Byrd in Pasco County Circuit Court.

Florida previously reached $878 million in settlements with CVS Health Corp (NYSE:CVS), Teva Pharmaceutical Industries (NYSE:TEVA) Ltd, Abbvie Inc's Allergan (NYSE:AGN) unit and Endo International (NASDAQ:ENDP) Plc.

Steven Derringer, Walgreen's attorney, said in his opening statement that the pharmacy chain filled prescriptions from doctors and did not ignore red flags that allowed opioids to flood Florida.

"There are so many pills because doctors have written so many prescriptions for pain medicine," Derringer said.

Florida has spent more than $14 billion to address the opioid crisis in the state, and opioid overdoses have caused nearly 40,000 deaths from 1999 to 2020, Webster told jurors.

Walgreens deserves a "huge chunk of the blame" for overdose deaths and the state's increased spending, Webster said.

Derringer countered that others should be blamed for the state's opioid epidemic including drug manufacturers who lied to pharmacies about addiction risk, U.S. Food and Drug Administration officials who approved the sale of opioids for chronic pain and doctors who wrote unnecessary prescriptions.

Florida has collected more than $3 billion in opioid litigation against drugmakers, distributors and pharmacies, according to Attorney General Ashley Moody. Most will be spent on efforts to mitigate the opioid crisis in the state.

In March, Walgreens rival CVS Health Corp agreed to pay Florida $484 million. Drugmakers Teva will pay $194.8 million, Allergan will pay $134.2 million and Endo will pay $65 million.

Walgreens previously argued it was immune from being sued based on a mere $3,000 settlement it reached with Florida in 2012, following an investigation into its record-keeping policies and efforts to prevent the diversion of opioid drugs.

© Reuters. FILE PHOTO: A Walgreens store is seen in Chicago, Illinois, U.S. February 11, 2021.  REUTERS/Eileen T. Meslar

Byrd ruled in March that the 2012 settlement addressed only a single record-keeping violation and did not protect Walgreens from other claims. The company has appealed her ruling.

While a large portion of the more than 500,000 U.S. deaths from overdoses in the past two decades were caused by the powerful opioid fentanyl and other illicit drugs, overuse of prescription pain medicines put countless Americans on the path to addiction.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.